Each year, an open group from within the University of Washington Health Sciences selects a Common Book that serves as a platform for students from across health professions to learn together on topics of common importance. Throughout the school year students have the opportunity to participate in a series of lectures, interactive discussions, advocacy efforts, and seminars focused on the major topic(s) of the book.

Founded in 1987 by Dr. Steve Gloyd, the University of Washington Department of Global Health Master of Public Health (MPH) program is one of the premier global health programs in the world, offering a unique combination of scholarship and activism.

Global health researchers at the University of Washington have received a $122 million grant from the Bill & Melinda Gates Foundation to test the effectiveness of the candidate drug islatravir, a once-a-month oral pill to prevent HIV.

The five-year grant will support the implementation of a Phase 3, randomized trial of islatravir, among women, in seven countries in sub-Saharan Africa. Islatravir is a nucleoside reverse transcriptase translocation inhibitor in development by Merck for the treatment and prevention of HIV-1 infection.

When Ana Gervassi went into panic mode forty-five minutes before the General Examinations for her doctoral degree, there was only one thing she could think to do. She went to the office of her faculty mentor, Lee Ann Campbell, a professor of global health and the director of the Interdisciplinary Pathobiology Program at the University of Washington.